Type
Closure
Country
France
Region
Location of affected unit(s)
Aubière, Dijon, Reims et Sophia-Antipolis, Bordeaux, Marseille, Nancy, Nantes, Rennes, Toulouse, Tours
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture Of Pharmaceutical Preparations

145 jobs
Number of planned job losses
Job loss
8 jobs
Number of planned job creations
Job creation
Announcement Date
21 November 2024
Employment effect (start)
1 June 2025
Foreseen end date
31 December 2025

Description

Boiron, a pharmaceutical laboratory, is undergoing internal restructuring, resulting in the loss of 145 jobs across various locations. Four sites: Aubière, Dijon, Reims and Sophia-Antipolis, will close between June and November 2025, leading to the loss of 73 jobs, including 15 in Aubière. The remaining job cuts will affect distribution centres in Bordeaux, Marseille, Nancy, Nantes, Rennes, Toulouse, and Tours.

Of the 145 positions being cut, 28 were vacant roles. As part of this reorganization, the company plans to create eight new positions in its pharmaceutical network.

This restructuring follows the non-reimbursement of homoeopathy in 2021, which had previously triggered the loss of 500 jobs in a prior internal reorganization in 2021: Laboratoires Boiron 2020 - FR.


Sources

Citation

Eurofound (2024), Boiron , Closure in France, factsheet number 201995, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/201995.